4//SEC Filing
Galante Joseph C 4
Accession 0001214659-24-005222
CIK 0001087294other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 8:31 PM ET
Size
4.8 KB
Accession
0001214659-24-005222
Insider Transaction Report
Form 4
Galante Joseph C
Director
Transactions
- Award
Common Stock
2024-03-25$1.71/sh+1,000$1,710→ 59,356 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 25, 2025.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001632384
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 8:31 PM ET
- Size
- 4.8 KB